Genmab A/S Files June 2024 Report (6-K)
Ticker: GNMSF · Form: 6-K · Filed: Jun 3, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
Related Tickers: GMAB
TL;DR
Genmab filed its June 6-K, rolling into existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on June 3, 2024, to report its activities for the month of June 2024. This report is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-277273.
Why It Matters
This filing serves as an update for investors regarding Genmab A/S's ongoing reporting requirements and its incorporation into existing registration statements.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would typically impact risk.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-24-008864 (filing_id) — Accession Number
- 333-232693 (registration_statement_id) — S-8 File Number
- 333-253519 (registration_statement_id) — S-8 File Number
- 333-262970 (registration_statement_id) — S-8 File Number
- 333-277273 (registration_statement_id) — S-8 File Number
FAQ
What type of report is Genmab A/S filing?
Genmab A/S is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What period does this 6-K report cover?
This report is for the month of June 2024.
What is the filing date of this report?
The filing date is June 3, 2024.
Which registration statements does this 6-K filing get incorporated into?
This 6-K filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Numbers 333-232693, 333-253519, 333-262970, and 333-277273.
What is the principal executive office address for Genmab A/S?
The principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Stats: 250 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-06-03 16:23:58
Filing Documents
- gmab-20240603x6k.htm (6-K) — 23KB
- gmab-20240603xex99d1.htm (EX-99.1) — 65KB
- gmab-20240603xex99d1a.htm (EX-99.1(A)) — 18055KB
- gmab-20240603xex99d1b.htm (EX-99.1(B)) — 11633KB
- gmab-20240603xex99d1001.jpg (GRAPHIC) — 5KB
- gmab-20240603xex99d1a001.jpg (GRAPHIC) — 5KB
- gmab-20240603xex99d1b001.jpg (GRAPHIC) — 5KB
- 0001558370-24-008864.txt ( ) — 29796KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF JUNE 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. nthony GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: JUNE 3, 2024 EXHIBIT INDEX O Exhibit Description of Exhibit 99.1 Company Announcement Dated June 3, 2024: Transactions in Connection with Share Buy-back Program 99.1(a) Appendix Share buyback program – Specification for May 27 – May 29, 2024 99.1(b) Appendix Share buyback program – Specification for May 30 – May 31, 2024